230 related articles for article (PubMed ID: 7523310)
1. Expression of neuronal src mRNA as a favorable marker and inverse correlation to N-myc gene amplification in human neuroblastomas.
Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Kawamura K; Etoh T; Takahashi H; Simizu B
Int J Cancer; 1994 Sep; 58(6):793-8. PubMed ID: 7523310
[TBL] [Abstract][Full Text] [Related]
2. Expression of alternatively spliced src messenger RNAs related to neuronal differentiation in human neuroblastomas.
Matsunaga T; Shirasawa H; Tanabe M; Ohnuma N; Takahashi H; Simizu B
Cancer Res; 1993 Jul; 53(13):3179-85. PubMed ID: 8319227
[TBL] [Abstract][Full Text] [Related]
3. Neuronal src and trk a protooncogene expression in neuroblastomas and patient prognosis.
Matsunaga T; Shirasawa H; Enomoto H; Yoshida H; Iwai J; Tanabe M; Kawamura K; Etoh T; Ohnuma N
Int J Cancer; 1998 Jun; 79(3):226-31. PubMed ID: 9645342
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of N-myc messenger RNA in neuroblastomas found by mass screening.
Matsunaga T; Shirasawa H; Hishiki T; Yoshida H; Kouchi K; Ohtsuka Y; Kawamura K; Etoh T; Ohnuma N
Clin Cancer Res; 2000 Aug; 6(8):3199-204. PubMed ID: 10955804
[TBL] [Abstract][Full Text] [Related]
5. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas.
Matsunaga T; Takahashi H; Ohnuma N; Tanabe M; Yoshida H; Iwai J; Shirasawa H; Simizu B
Cancer Res; 1991 Jun; 51(12):3148-52. PubMed ID: 2039993
[TBL] [Abstract][Full Text] [Related]
6. The expression profile of alternatively spliced neuronal c-src RNA distinguishes between human tumours of the sympatho-adrenal lineage.
Ortoft E; Bjelfman C; Hedborg F; Grimelius L; Påhlman S
Int J Cancer; 1995 Jan; 60(1):38-44. PubMed ID: 7529211
[TBL] [Abstract][Full Text] [Related]
7. Inverse correlation between expression of multidrug resistance gene and N-myc oncogene in human neuroblastomas.
Nakagawara A; Kadomatsu K; Sato S; Kohno K; Takano H; Akazawa K; Nose Y; Kuwano M
Cancer Res; 1990 May; 50(10):3043-7. PubMed ID: 2185879
[TBL] [Abstract][Full Text] [Related]
8. Identification of subsets of neuroblastomas by combined histopathologic and N-myc analysis.
Shimada H; Stram DO; Chatten J; Joshi VV; Hachitanda Y; Brodeur GM; Lukens JN; Matthay KK; Seeger RC
J Natl Cancer Inst; 1995 Oct; 87(19):1470-6. PubMed ID: 7674334
[TBL] [Abstract][Full Text] [Related]
9. The high level of hCDC10 gene expression in neuroblastoma may be associated with favorable characteristics of the tumor.
Nagata T; Takahashi Y; Asai S; Ishii Y; Mugishima H; Suzuki T; Chin M; Harada K; Koshinaga S; Ishikawa K
J Surg Res; 2000 Aug; 92(2):267-75. PubMed ID: 10896833
[TBL] [Abstract][Full Text] [Related]
10. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
[TBL] [Abstract][Full Text] [Related]
11. trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study.
Tanaka T; Hiyama E; Sugimoto T; Sawada T; Tanabe M; Ida N
Cancer; 1995 Sep; 76(6):1086-95. PubMed ID: 8625212
[TBL] [Abstract][Full Text] [Related]
12. Expression of the neuronal form of pp60c-src in neuroblastoma in relation to clinical stage and prognosis.
Bjelfman C; Hedborg F; Johansson I; Nordenskjöld M; Påhlman S
Cancer Res; 1990 Nov; 50(21):6908-14. PubMed ID: 1698545
[TBL] [Abstract][Full Text] [Related]
13. N-myc genomic content and DNA ploidy in stage IVS neuroblastoma.
Bourhis J; Dominici C; McDowell H; Raschella G; Wilson G; Castello MA; Plouvier E; Lemerle J; Riou G; Bénard J
J Clin Oncol; 1991 Aug; 9(8):1371-5. PubMed ID: 2072140
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation of N-myc gene amplification with prognosis in localized neuroblastoma: a Pediatric Oncology Group study.
Cohn SL; Look AT; Joshi VV; Holbrook T; Salwen H; Chagnovich D; Chesler L; Rowe ST; Valentine MB; Komuro H
Cancer Res; 1995 Feb; 55(4):721-6. PubMed ID: 7850780
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM
Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489
[TBL] [Abstract][Full Text] [Related]
16. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
[TBL] [Abstract][Full Text] [Related]
17. N-myc amplification and cell proliferation rate in human neuroblastoma.
Pession A; Trerè D; Perri P; Rondelli R; Montanaro L; Mantovani W; Derenzini M; Paolucci G
J Pathol; 1997 Nov; 183(3):339-44. PubMed ID: 9422991
[TBL] [Abstract][Full Text] [Related]
18. Application of fluorescence in situ hybridization to detect N-myc (MYCN) gene amplification on paraffin-embedded tissue sections of neuroblastomas.
Hachitanda Y; Saito M; Mori T; Hamazaki M
Med Pediatr Oncol; 1997 Aug; 29(2):135-8. PubMed ID: 9180916
[TBL] [Abstract][Full Text] [Related]
19. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
Nakagawara A; Arima M; Azar CG; Scavarda NJ; Brodeur GM
Cancer Res; 1992 Mar; 52(5):1364-8. PubMed ID: 1737399
[TBL] [Abstract][Full Text] [Related]
20. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
